Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: October 2016

Workgroups: Medical Product Safety Workgroup, Substance Use Workgroup

This report presents information and data on pediatric emergency department visits for children who ingested buprenorphine/naloxone. Because of young children’s unsupervised ingestion of these medicines, in 2010-2011, buprenorphine/ naloxone was the most common cause of children’s hospitalization for medication ingestion. 

Read more about this resource

Objectives related to this resource (1)

Reduce emergency department visits related to nonmedical use of prescription opioids — MPS‑02
Target met or exceeded

Suggested Citation

1.

Budnitz, D. S. (2016). Notes from the field: pediatric emergency department visits for buprenorphine/naloxone ingestion—United States, 2008–2015. MMWR. Morbidity and mortality weekly report, 65. doi: http://dx.doi.org/10.15585/mmwr.mm6541a5